See more : Startek, Inc. (SRT) Income Statement Analysis – Financial Results
Complete financial analysis of Precipio, Inc. (PRPO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Precipio, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- CNA Financial Corporation (CNA) Income Statement Analysis – Financial Results
- Nanjing Sciyon Wisdom Technology Group Co., Ltd. (002380.SZ) Income Statement Analysis – Financial Results
- Valuence Merger Corp. I (VMCAW) Income Statement Analysis – Financial Results
- Shenzhen Colibri Technologies Co., Ltd. (002957.SZ) Income Statement Analysis – Financial Results
- Airship AI Holdings, Inc. (AISPW) Income Statement Analysis – Financial Results
Precipio, Inc. (PRPO)
About Precipio, Inc.
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.20M | 9.41M | 8.85M | 6.09M | 3.13M | 2.86M | 1.72M | 1.56M | 1.65M | 27.08M | 27.54M | 31.48M | 31.97M | 20.05M | 22.02M | 23.99M | 23.18M | 23.42M | 25.83M | 33.79M | 33.87M | 37.55M | 38.47M | 25.88M | 23.03M |
| Cost of Revenue | 9.18M | 6.90M | 6.46M | 4.94M | 2.91M | 2.64M | 1.43M | 1.76M | 1.94M | 17.36M | 15.05M | 16.47M | 13.53M | 10.28M | 10.42M | 10.35M | 10.48M | 12.05M | 13.50M | 24.60M | 24.32M | 19.57M | 17.20M | 10.89M | 10.58M |
| Gross Profit | 6.02M | 2.51M | 2.39M | 1.15M | 219.00K | 225.00K | 292.00K | -205.00K | -287.00K | 9.72M | 12.50M | 15.01M | 18.44M | 9.76M | 11.61M | 13.65M | 12.69M | 11.37M | 12.33M | 9.19M | 9.55M | 17.99M | 21.27M | 14.99M | 12.46M |
| Gross Profit Ratio | 39.60% | 26.67% | 27.03% | 18.88% | 7.00% | 7.86% | 16.95% | -13.17% | -17.36% | 35.89% | 45.37% | 47.68% | 57.67% | 48.70% | 52.69% | 56.88% | 54.77% | 48.55% | 47.74% | 27.21% | 28.20% | 47.89% | 55.29% | 57.92% | 54.09% |
| Research & Development | 0.00 | 1.70M | 1.30M | 1.20M | 1.20M | 1.10M | 500.00K | 1.42M | 1.85M | 2.90M | 3.21M | 2.49M | 2.22M | 2.31M | 3.18M | 2.47M | 3.03M | 2.36M | 2.20M | 6.69M | 9.31M | 12.20M | 9.37M | 7.65M | 6.30M |
| General & Administrative | 10.32M | 13.51M | 10.61M | 9.00M | 8.32M | 9.45M | 6.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 0.00 | 8.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.42M | 13.61M | 10.71M | 9.10M | 8.42M | 9.45M | 6.49M | 6.19M | 7.06M | 24.15M | 25.04M | 22.02M | 19.15M | 10.93M | 10.32M | 10.80M | 11.47M | 12.14M | 12.22M | 17.50M | 17.32M | 24.20M | 21.64M | 14.91M | 11.53M |
| Other Expenses | 3.22M | 15.31M | 12.01M | 10.30M | 9.62M | -1.33M | 877.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 425.00K | 10.50M | 4.77M | 0.00 | 0.00 | 1.91M | 1.51M |
| Operating Expenses | 13.64M | 15.31M | 12.01M | 10.30M | 9.62M | 9.45M | 6.49M | 7.61M | 8.91M | 27.04M | 28.26M | 24.51M | 21.37M | 13.24M | 13.50M | 13.26M | 14.50M | 14.50M | 14.84M | 34.68M | 31.40M | 36.40M | 31.01M | 24.47M | 19.34M |
| Cost & Expenses | 22.82M | 22.21M | 18.46M | 15.24M | 12.53M | 12.09M | 7.92M | 9.38M | 10.85M | 44.41M | 43.30M | 40.98M | 34.90M | 23.52M | 23.92M | 23.61M | 24.98M | 26.55M | 28.34M | 59.28M | 55.72M | 55.97M | 48.21M | 35.36M | 29.92M |
| Interest Income | 0.00 | 12.00K | 20.00K | 470.00K | 2.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 74.00K | 270.00K | 216.00K | 0.00 | 0.00 | 160.00K | 626.00K | 2.45M | 2.01M | 0.00 |
| Interest Expense | 18.00K | 12.00K | 20.00K | 470.00K | 473.00K | 0.00 | 2.32M | 0.00 | 0.00 | 665.00K | 642.00K | 888.00K | 958.00K | 4.00K | 15.00K | 74.00K | 0.00 | 11.00K | 1.98M | 2.38M | 315.00K | 62.00K | 58.00K | 1.78M | 0.00 |
| Depreciation & Amortization | 1.52M | 1.52M | 1.44M | 1.36M | 1.35M | 1.27M | 743.00K | 112.00K | 489.00K | 2.25M | 2.75M | 2.28M | 2.10M | 708.00K | 855.00K | 882.00K | 950.00K | 1.95M | 4.28M | 4.01M | 8.75M | 3.99M | 3.68M | 1.91M | 1.51M |
| EBITDA | -4.32M | -10.65M | -7.05M | -8.77M | -8.22M | -7.96M | -5.45M | -1.60M | -8.65M | -10.51M | -12.65M | -5.02M | -830.00K | -2.27M | -1.04M | 600.00K | -981.00K | -973.00K | 1.77M | -6.76M | -7.44M | -18.28M | -6.06M | -7.57M | -5.37M |
| EBITDA Ratio | -28.41% | -119.82% | -92.32% | -109.24% | -205.50% | -111.66% | 353.86% | -523.12% | -513.43% | -80.83% | -58.52% | -22.95% | 15.70% | -16.26% | -8.62% | 8.39% | -1.99% | -5.02% | 10.32% | -12.99% | -21.96% | -29.33% | -15.67% | -32.22% | -23.31% |
| Operating Income | -7.62M | -12.80M | -9.61M | -9.15M | -9.40M | -13.91M | -15.51M | -7.82M | -9.20M | -17.32M | -15.76M | -9.50M | -2.97M | -3.61M | -1.90M | -368.00K | -3.32M | -3.13M | -2.51M | -29.06M | -22.59M | -21.70M | -9.74M | -9.48M | -6.88M |
| Operating Income Ratio | -50.14% | -135.96% | -108.63% | -150.13% | -300.74% | -485.75% | -900.23% | -502.18% | -556.26% | -63.96% | -57.21% | -30.19% | -9.30% | -18.02% | -8.61% | -1.53% | -14.33% | -13.37% | -9.72% | -86.00% | -66.70% | -57.78% | -25.32% | -36.61% | -29.88% |
| Total Other Income/Expenses | 1.77M | 619.00K | 1.10M | -1.45M | -2.32M | -2.06M | -5.18M | -515.00K | -1.22M | 3.90M | -282.00K | 1.32M | -6.77M | 628.00K | 18.00K | 86.00K | 243.00K | 198.00K | -2.45M | -5.26M | -5.82M | -2.98M | 2.36M | 996.00K | -1.20M |
| Income Before Tax | -5.85M | -12.18M | -8.52M | -10.60M | -13.31M | -15.97M | -20.69M | -8.27M | -10.14M | -13.42M | -16.04M | -8.18M | -9.74M | -2.98M | -1.88M | -282.00K | -1.93M | -2.93M | -4.96M | -34.47M | -22.89M | -21.26M | -7.38M | -8.48M | -8.08M |
| Income Before Tax Ratio | -38.51% | -129.39% | -96.25% | -173.97% | -425.74% | -557.72% | -1,201.04% | -531.09% | -613.31% | -49.54% | -58.24% | -25.99% | -30.46% | -14.88% | -8.53% | -1.18% | -8.33% | -12.53% | -19.20% | -102.00% | -67.60% | -56.61% | -19.18% | -32.77% | -35.08% |
| Income Tax Expense | 0.00 | 25.00K | 33.00K | 1.63M | -70.00K | -279.00K | 13.87M | -203.00K | 23.76M | 524.00K | -54.00K | 146.00K | 45.00K | 150.00K | 42.00K | 213.00K | 243.00K | 30.00K | 26.00K | -94.00K | 65.00K | 105.00K | 24.00K | 180.00K | 1.75M |
| Net Income | -5.85M | -12.20M | -8.55M | -12.23M | -13.24M | -15.69M | -20.69M | -7.62M | -32.95M | -13.94M | -15.99M | -8.33M | -9.78M | -3.13M | -1.92M | -495.00K | -2.11M | -3.43M | -14.99M | -34.37M | -22.96M | -21.37M | -7.40M | -8.66M | -9.83M |
| Net Income Ratio | -38.51% | -129.65% | -96.62% | -200.76% | -423.50% | -547.97% | -1,201.04% | -489.15% | -1,993.59% | -51.48% | -58.04% | -26.45% | -30.60% | -15.63% | -8.72% | -2.06% | -9.09% | -14.65% | -58.05% | -101.73% | -67.79% | -56.89% | -19.24% | -33.46% | -42.66% |
| EPS | -4.51 | -10.73 | -8.10 | -14.84 | -46.51 | -217.81 | -1.34K | -158.45K | -24.07K | -837.26 | -990.09 | -646.66 | -1.07K | -343.68 | -210.78 | -54.34 | -231.31 | -376.70 | -2.27K | -6.40K | -5.06K | -4.89K | -1.77K | -2.81K | -4.08K |
| EPS Diluted | -4.51 | -10.73 | -8.10 | -14.84 | -46.51 | -217.80 | -1.34K | -158.45K | -24.07K | -837.26 | -990.09 | -646.66 | -1.07K | -343.68 | -210.78 | -54.34 | -231.31 | -376.70 | -2.27K | -6.40K | -5.06K | -4.89K | -1.77K | -2.81K | -4.08K |
| Weighted Avg Shares Out | 1.30M | 1.14M | 1.05M | 823.85K | 284.76K | 72.06K | 15.46K | 48.06 | 1.37K | 16.65K | 16.15K | 12.88K | 9.14K | 9.12K | 9.11K | 9.11K | 9.11K | 9.11K | 6.61K | 5.37K | 4.53K | 4.37K | 4.18K | 3.08K | 2.41K |
| Weighted Avg Shares Out (Dil) | 1.30M | 1.14M | 1.05M | 823.85K | 284.76K | 72.06K | 15.46K | 48.06 | 1.37K | 16.65K | 16.15K | 12.88K | 9.14K | 9.12K | 9.11K | 9.11K | 9.11K | 9.11K | 6.61K | 5.37K | 4.53K | 4.37K | 4.18K | 3.08K | 2.41K |
Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven
These efficiencies plus revenue growth expected to continue the positive momentum These efficiencies plus revenue growth expected to continue the positive momentum
Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023
Revenue growth and customer pipeline advance the Company towards breakeven Revenue growth and customer pipeline advance the Company towards breakeven
Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript
Precipio, Inc. (NASDAQ:PRPO ) Q1 2023 Earnings Conference Call May 17, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio Q1 2023 Shareholder Update Conference Call. All participants will be in...
Precipio, Inc. (PRPO) Q4 2022 Earnings Call Transcript
Precipio, Inc. (NASDAQ:PRPO ) Q4 2022 Earnings Conference Call April 3, 2023 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Welcome to the Precipio shareholder 2022 Fourth Quarter and Year-End Shareholder Update Conference Call. All...
Precipio, Inc. (PRPO) Q3 2022 Earnings Call Transcript
Precipio, Inc. (NASDAQ:PRPO ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants Operator Welcome to the Precipio Shareholder Third Quarter 2022 Shareholder Update Conference Call. All...
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2022 Results - Earnings Call Transcript
Precipio, Inc. (NASDAQ:PRPO ) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Ilan Danieli - Founder, President, CEO & Director Conference Call Participants Operator Welcome to the Precipio Shareholder -- Second Quarter 2022 Shareholder Update...
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , is excited to announce its participation and the presentation of HemeScreen, its novel diagnostic technology platform, at the Executive War College...
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2021 Results - Earnings Call Transcript
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2021 Results - Earnings Call Transcript
Best Penny Stocks to Buy Today? 3 For Your Watchlist Right Now
Which penny stocks are you watching right now? The post Best Penny Stocks to Buy Today?
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q3 2021 Results - Earnings Call Transcript
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q3 2021 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports